Disclosure Panels Details Page
Ovarian Cancer Panel - Disclosures as of 10/23/2019
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Ronald Alvarez MD, MBA | GOG Unleash |
AbbVie, Inc. Eisai Inc. Genentech, Inc. TESARO, Inc. |
None | None | ✔ |
| Deborah Armstrong MD | advaxis AstraZeneca Pharmaceuticals LP Clovis Oncology Morphotek Inc. Pfizer Inc. Syndax TESARO, Inc. |
Cue Biopharma | None | None | ✔ |
| Jamie Bakkum-Gamez MD | None | None | None | None | ✔ |
| Lisa Barroilhet MD, MSc | None | None | None | None | - |
| Kian Behbakht MD | None | Clovis Oncology | None | None | ✔ |
| Andrew Berchuck MD | AbbVie, Inc. Amgen Inc. AstraZeneca Pharmaceuticals LP Boehringer Ingelheim GmbH Bristol Myers Squibb Genentech, Inc. GOG partners GSK Incyte Corporation Merck & Co., Inc. Pharmamar TESARO, Inc. |
None | None | None | ✔ |
| Jonathan Berek MD, MMS | TESARO, Inc. | None | None | None | - |
| Marian Birkeland PhD | None | None | None | None | - |
| Jennifer Burns BS | None | None | None | None | ✔ |
| Lee-May Chen MD | None | None | None | None | ✔ |
| Mihaela Cristea MD | ImmunoGen, Inc. | AbbVie, Inc. | AstraZeneca Pharmaceuticals LP | None | ✔ |
| Marie DeRosa RN | None | None | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Eric Eisenhauer MD | NA | NA | NA | NA | - |
| Adam ElNaggar MD | AstraZeneca Pharmaceuticals LP Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
AstraZeneca Pharmaceuticals LP Caris Life Sciences Clovis Oncology TESARO, Inc. |
None | None | ✔ |
| Anita Engh PhD | None | None | None | None | ✔ |
| David Gershenson MD | National Cancer Institute Novartis Pharmaceuticals Corporation |
Genentech, Inc. | OncLive | Biogen Idec|Celgene Corporation|Elsevier|Johnson & Johnson|UpToDate | ✔ |
| Heidi Gray MD | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Ardeshir Hakam MD | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Angela Jain MD | None | None | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Charles Leath III MD, MSPH | Celsion PAREXEL International Corporation |
AbbVie, Inc. Clovis Oncology Eisai Inc. Syros Pharmaceuticals Unleash Immuno Oncolytics |
None | None | ✔ |
| Joyce Liu MD, MPH | Arch Oncology AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Clovis Oncology CytoMX EMD Serono Genentech, Inc. National Cancer Institute Regeneron Pharmaceuticals, Inc. TESARO, Inc. Vigeo Therapeutics |
AstraZeneca Pharmaceuticals LP Clovis Oncology Merck & Co., Inc. Mersana Therapeutics TESARO, Inc. |
None | None | ✔ |
| Haider Mahdi MD, MPH | None | None | None | None | ✔ |
| Lainie Martin MD | None | Immunogen | None | None | ✔ |
| Daniela Matei MD | None | AstraZeneca Pharmaceuticals LP Radius |
None | None | ✔ |
| Michael McHale MD | Verastem | Eisai Inc. Legal Firm TESARO, Inc. |
None | None | - |
| Karen McLean MD, PhD | None | None | None | None | ✔ |
| David O'Malley MD | AbbVie, Inc. Acerta Pharma Advaxis Agenus Ajinomoto Co, Inc Ambry Genetics Array BioPharma Inc. AstraZeneca Pharmaceuticals LP Bristol Myers Squibb CERULEAN Clovis Oncology Eisai Inc. EMD Serono ERGOMED Clinical Research Ltd Exelixis Inc. Genentech, Inc. Genmab GOG Foundation GSK ImmunoGen, Inc. INC Research, Inc inVentiv Health Clinical Iovance Janssen Pharmaceutica Products, LP LEAP Therapeutics Ludwig Cancer Research, Marker Therapeutics (prior TapImmune) Merck & Co., Inc. National Cancer Institute Novartis Pharmaceuticals Corporation Novocure Pfizer Inc. PRA International Regeneron Pharmaceuticals, Inc. sanofi-aventis U.S. Seattle Genetics, Inc. Serono Inc TESARO, Inc. Tracon VentiRx Pharmaceuticals Watermark |
AbbVie, Inc. Ambry Genetics AstraZeneca Pharmaceuticals LP Clovis Oncology Eisai Inc. Genelux Genentech, Inc. ImmunoGen, Inc. Iovance Janssen Pharmaceutica Products, LP Novocure OncoQuest Regeneron Pharmaceuticals, Inc. TESARO, Inc. Translational Genomics/Cordgenics |
None | None | ✔ |
| Sharon Park PharmD, BCOP | None | None | None | None | - |
| Sanja Percac-Lima MD, PhD | None | Law firm Goodell, De Vries, Leech & Dann, LLP Baltimore MD | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Elena Ratner MD, MBA | Covidien AG | Genentech, Inc. guidepoint consulting Legal expert witness TESARO, Inc. |
Zai labs | None | ✔ |
| Leslie Ray PharmD | None | None | None | None | ✔ |
| Steven Remmenga MD | None | NCCN Radius | Humana-TRICARE Quality Committee | None | ✔ |
| Paul Sabbatini MD | Bristol Myers Squibb | None | None | None | ✔ |
| Bettyanne Sunderland BSN, OCN | None | None | None | None | ✔ |
| Erin Vidic | None | None | None | None | - |
| Theresa Werner MD | AbbVie, Inc. Bristol Myers Squibb Clovis Oncology Genentech, Inc. TESARO, Inc. |
None | None | None | ✔ |
| Emese Zsiros MD, PhD | None | Iovance Biotherapeutics | None | None | ✔ |